Creative Planning Global Blood Therapeutics, Inc. Transaction History

Creative Planning

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 23, 2020	SELL	$48.73 - $81.82 $97,460 - $163,640	-2,000 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$41.72 - $87.2 $83,440 - $174,400	2,000 New	2,000 $102,000
Q1 2019 Apr 24, 2019	SELL	$39.99 - $53.48 $2.93 Million - $3.91 Million	-73,200 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$31.54 - $46.67 $1.59 Million - $2.36 Million	50,472 Added 222.07%	73,200 $3.01 Million
Q3 2018 Oct 25, 2018	SELL	$38.0 - $51.1 $38 - $51	-1 Reduced -0.0%	22,728 $864,000
Q2 2018 Jul 20, 2018	BUY	$38.7 - $50.15 $879,612 - $1.14 Million	22,729 New	22,729 $1.03 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.